P01
|
Update on functional drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
Poster
1. New developments in 3D cell culture for functional precision medicine
H. Peterziel Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. Becker Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Loboda Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Schmidt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Herter Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergX. Gerloff Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergR. Autry Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergT. Holland-Letz German Cancer Research Center (DKFZ)A. Kopp-Schneider German Cancer Research Center (DKFZ)O. Witt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. Oehme
Presenter
Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
|
P02
|
|
P03
|
Potential of 3D skin models in genetic research of ARCI
Poster
3. Clinical applications and regenerative medicine
H. Hsu-Rehder Medical Center - University of FreiburgC. Glocker Medical Center - University of FreiburgC. Aldrian Medical Center - University of FreiburgE. Dikici
Presenter
Medical Center - University of FreiburgJ. Fischer Medical Center - University of Freiburg
|
P04
|
|
P05
|
|
P06
|
Optical oxygen measurements using confocal instruments
Poster
6. Analysis in 3D
M. Klesen Karlsruhe Institute of Technology (KIT)C. Nies Karlsruhe Institute of Technology (KIT)C. Grün
Presenter
Karlsruhe Institute of Technology (KIT)E. Gottwald Karlsruhe Institute of Technology (KIT)
|
P07
|
Modeling and targeting the tumor microenvironment in therapy resistant neuroblastomas
Poster
2. 3D models for drug development/discovery
M. Emperador Melero
Presenter
Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. RÖSCH Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. HERTER Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergO. ERMAKOVA Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergL. RANGEL School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology SydneyJ. BRAND Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyJ. MURRAY Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyM. HARBER Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyE. DOLMAN Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyF. VALDES-MORA Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales SydneyD. GALLEGO-ORTEGA School of Biomedical Engineering, Faculty of Engineering and Information Technology, University of Technology SydneyH. PETERZIEL Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergO. WITT Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. OEHME Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
|
P08
|
Multi-parametric drug screening identifies specific vulnerabilities of mesenchymal neuroblastomas
Poster
5. Automation and further enabling technologies
S. Herter
Presenter
Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergM. Emperador Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Smyrilli Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergD. Kocher Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Celikyürekli Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergC. Zeiser Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergS. Kreth Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Henrich Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergK. Maass Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergJ. Rettenmeier Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergH. Peterziel Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergF. Westermann Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergA. Hamacher Brady Johns Hopkins University BaltimoreO. Witt Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) HeidelbergI. Oehme Hopp Children’s Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK) Heidelberg
|
P09
|
|
P10
|
In-vitro models to study antiviral mechanism of influenza defective interfering particles
Poster
2. 3D models for drug development/discovery
P. Opitz
Presenter
Otto-von-Guericke University MagdeburgD. Rüdiger Max Planck Institute for Dynamics of Complex Technical SystemsN. Wynserski Max Planck Institute for Dynamics of Complex Technical SystemsS. Kupke Max Planck Institute for Dynamics of Complex Technical SystemsU. Reichl Max Planck Institute for Dynamics of Complex Technical Systems
|
P11
|
|
P12
|
Human brown and beige adipocyte 3D Cell Culture models for enhanced functional insights
Poster
2. 3D models for drug development/discovery
A. Wagner
Presenter
Technical University of MunichT. Dinh Technical University of MunichF. Acosta Turku University Hospital, FinlandJ. Örling Turku University Hospital, FinlandM. Wabitsch University Medical Center UlmK. Virtanen Turku University Hospital, FinlandM. Klingenspor Technical University of Munich
|
P13
|
|
P14
|
|
P15
|
A systematic cell culture array for efficient generation of human long-term 3D sarcoma models
Poster
1. New developments in 3D cell culture for functional precision medicine
C. Dagostino
Presenter
National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZW. Hussain National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZJ. Paluncic National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZM. Zoccoler Technical University of Dresden, GermanyJ. Pablik University Hospital Carl Gustav CarusD. Richter National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZA. Klimova Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität DresdenA. Banito Hopp Children's Cancer Center, Heidelberg (KiTZ)J. Wagner German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)I. Mateska National Center for Tumor Diseases Dresden (NCT/UCC) and DKFZS. Schulze University Hospital Carl Gustav Carus, TUDD. Stange University Hospital Carl Gustav CarusI. Oehme Hopp Children’s Cancer Center Heidelberg (KiTZ)S. Richter National Center for Tumor Diseases Dresden (NCT/UCC), Sarcoma Center, University Hospital Carl Gustav Carus Dresden, Dresden University of TechnologyS. Pfister Hopp Children's Cancer Center Heidelberg (KiTZ)S. Fröhling National Center for Tumor Diseases (NCT)C. Scholl German Cancer Research Center (DKFZ)J. Weitz University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität DresdenK. Schaser University Hospital Carl Gustav Carus, TUDC. Heining National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTKH. Glimm National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTKC. Ball National Center for Tumor Diseases Dresden (NCT/UCC) Dresden, DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TU Dresden, DKTK
|
P16
|
|
P17
|
|
P18
|
|
P19
|
|
P20
|
Three-dimensional co-culture model for patient-specific B-cell lymphomas
Poster
2. 3D models for drug development/discovery
T. Fleischhammer
Presenter
Gottfried Wilhelm Leibniz University HannoverN. Qin University Clinic Düsseldorf, GermanyS. Dietrich University Clinic Düsseldorf, GermanyI. Pepelanova Gottfried Wilhelm Leibniz University HannoverA. Lavrentieva Gottfried Wilhelm Leibniz University Hannover
|
P21
|
|
P22
|
Automation of long term dynamic drug testing for clinical implementation of real world precision oncology
Poster
5. Automation and further enabling technologies
O. Mauti PreComb Therapeutics AGD. Felder Eastern Switzerland University of Applied SciencesL. Müller Eastern Switzerland University of Applied SciencesA. Koller Eastern Switzerland University of Applied SciencesM. Herzog University Hospital ZurichS. Kollar University Hospital ZurichC. Pauli University Hospital ZurichP. Steiner PreComb Therapeutics AGJ. Kelm
Presenter
PreComb Therapeutics AG
|
P23
|
Shortening of incubation times for the dissociation of 3D cell cultures
Poster
5. Automation and further enabling technologies
S. Hartmann-Fattler
Presenter
Fraunhofer Institute for Manufacturing Engineering and Automation IPAF. Mayerle Fraunhofer Institute for Manufacturing Engineering and Automation IPAS. Knoth Fraunhofer Institute for Manufacturing Engineering and Automation IPAP. Lebhardt Fraunhofer Institute for Manufacturing Engineering and Automation IPA
|
P24
|
|
P25
|
A practical guide to tumour spheroids in cancer nanomedicine research
Poster
2. 3D models for drug development/discovery
A. Evtushenko
Presenter
University of CambridgeC. Yadav University of CambridgeB. Lozano-Torres University of CambridgeA. Bistrovic Popov University of CambridgeL. Dvinskikh University of CambridgeC. Kaminski University of CambridgeL. Fruk University of Cambridge
|
P26
|
|
P27
|
Microfluidic-driven culture and automated analysis of colon cancer spheroids using light sheet microscopy
Poster
6. Analysis in 3D
A. Hermann
Presenter
Institute for Bioprocessing and Analytical Measurement Techniques e.V.F. Moll Institute for Bioprocessing and Analytical Measurement Techniques e.V.R. Römer Institute for Bioprocessing and Analytical Measurement Techniques e.V.S. Wiedermeier Institute for Bioprocessing and Analytical Measurement Techniques e.V.K. Lemke Institute for Bioprocessing and Analytical Measurement Techniques e.V.
|
P28
|
User-friendly droplet-based high-throughput cell viability assay for drug screening in tumor spheroids
Poster
2. 3D models for drug development/discovery
M. Saupe Institute for Bioprocessing and Analytical Measurement Techniques e.V.S. Wiedemeier Institute for Bioprocessing and Analytical Measurement Techniques e.V.F. Moll Institute for Bioprocessing and Analytical Measurement Techniques e.V.R. Römer Institute for Bioprocessing and Analytical Measurement Techniques e.V.K. Lemke
Presenter
Institute for Bioprocessing and Analytical Measurement Techniques e.V.
|
P29
|
|
P30
|
|
P31
|
|
P32
|
|
P33
|
|
P34
|
|
P35
|
|
P36
|
|
P37
|
|
P38
|
|
P39
|
|
P40
|
|
P41
|
A standardized 3D model for oncology research
Poster
1. New developments in 3D cell culture for functional precision medicine
C. Yadav
Presenter
University of CambridgeA. Evtushenko University of CambridgeA. Popov University of CambridgeB. Torres University of CambridgeA. Baker University of CambridgeL. Fruk University of Cambridge
|
P42
|
|
P43
|
|
P44
|
Enable better research with R.E.A.L skin: Realistic, Ethical, Automated and Layered
Poster
1. New developments in 3D cell culture for functional precision medicine
A. Reigl
Presenter
Fraunhofer Project-Group TigerShark Science K. Tiltmann Fraunhofer Project-Group TigerShark Science N. Köder Fraunhofer Project-Group TigerShark Science A. Hauser Fraunhofer Project-Group TigerShark Science L. Königer Fraunhofer Project-Group TigerShark Science S. Zöphel University Hospital Würzburg P. Klose Julius-Maximilians UniversityL. Kiesewetter Fraunhofer Institut für Silicatforschung ISCM. Ackermann REBIRTH Research Center for translational and regenerative medicineM. Schinke Fraunhofer Institute for Toxicology and Experimental Medicine ITEMN. Lachmann Fraunhofer Institute for Toxicology and Experimental Medicine ITEMA. Weghofer Eberhard-Karls-UniversityP. Loskill NMI Natural and Medical Sciences Institute at the University of TübingenF. Groeber-Becker Fraunhofer Institut für Silicatforschung ISCD. Groneberg Fraunhofer Institut für Silicatforschung ISC
|
P45
|
|
P46
|
|
P47
|
|
P48
|
Semi-automated multiplex readout of chemotherapeutic treatments using primary patient-derived cancer organoids & spheroids
Poster
1. New developments in 3D cell culture for functional precision medicine
D. Holthaus Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielA. Quevedo-Olmos Laboratory of Infection Oncology, Institute of Clinical Molecular Biology, CAU & UKSHJ. Schiepanski Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielJ. Dittrich Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielC. Rogmans Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielJ. Weimer Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielM. van Mackelenbergh Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielN. Maass Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus KielD. Bauerschlag Clinic and Polyclinic for Gynaecology and Reproductive Medicine, University Hospital JenaN. Hedemann
Presenter
Department of Gynecology and Obstetrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel
|
P49
|
Functional immuno- and chemotherapeutic testing of cervical cancer organoids
Poster
1. New developments in 3D cell culture for functional precision medicine
D. Holthaus
Presenter
University Hospital Schleswig-Holstein, Campus KielC. Rogmans University Hospital Schleswig-Holstein, Campus KielI. Gursinski University Hospital Schleswig-Holstein, Campus KielA. Quevedo-Olmos Institute of Clinical Molecular BiologyC. Peters University Hospital Schleswig-Holstein, Campus KielM. Ehsani Institute of Clinical Molecular BiologyJ. Weimer University Hospital Schleswig-Holstein, Campus KielN. Maass University Hospital Schleswig-Holstein, Campus KielM. van Mackelenbergh University Hospital Schleswig-Holstein, Campus KielD. Bauerschlag University Hospital Schleswig-Holstein, Campus KielD. Kabelitz University Hospital Schleswig-Holstein, Campus KielT. Meyer Institute of Clinical Molecular BiologyN. Hedemann University Hospital Schleswig-Holstein, Campus Kiel
|
P50
|
|
P51
|
|
P52
|
Automated cell perfusion for 3D cell culture and tissue engineering
Poster
5. Automation and further enabling technologies
C. Ivanova
Presenter
Microfluidics Innovation CenterO. Fournier Microfluidics Innovation CenterT. Gavoille Microfluidics Innovation CenterA. Morin Microfluidics Innovation CenterC. Betterelli Giuliano Microfluidics Innovation CenterE. Bancel Microfluidics Innovation CenterA. Geffrault Microfluidics Innovation CenterJ. Sepulveda Microfluidics Innovation Center
|
P53
|
|
P54
|
Modeling immunotherapies in live 3D human cancer tissue perfusion bioreactors
Poster
1. New developments in 3D cell culture for functional precision medicine
Y. Zhang
Presenter
University Hospital and Comprehensive Cancer Center TübingenP. Bucher University TübingenJ. Leibold University TübingenJ. Feucht University TübingenL. Flatz University Hospital TübingenC. Schürch University Hospital and Comprehensive Cancer Center Tübingen
|
P55
|
An innovative bioartificial graft system
Poster
3. Clinical applications and regenerative medicine
C. Blume
Presenter
Leibniz University HannoverS. Loewner Gottfried Wilhelm Leibniz University HannoverJ. Krueger Gottfried Wilhelm Leibniz University HannoverS. Heene Gottfried Wilhelm Leibniz University Hannover
|
P56
|
|
P57
|
|
P58
|
|
P59
|
|
P60
|
Use of biopsy-derived tumor organoid for personalized drug testing in recurrent glioblastoma
Poster
2. 3D models for drug development/discovery
A. Wöllner
Presenter
University Hospital HeidelbergR. Warta University Hospital HeidelbergJ. Cao University Hospital HeidelbergM. Arquilla University Hospital HeidelbergA. Paul University Hospital HeidelbergG. Jungwirth University Hospital HeidelbergW. Wick University Hospital HeidelbergA. von Deimling University Hospital HeidelbergS. Krieg University Hospital HeidelbergA. Unterberg University Hospital HeidelbergM. Jakobs University Hospital HeidelbergC. Herold-Mende University Hospital Heidelberg
|
P61
|
|
P62
|
|
P63
|
Time resolved mapping of oxygen consumption and extracellular acidification in 3D tissue models
Poster
6. Analysis in 3D
T. Naber
Presenter
Fraunhofer Institute for Electronic Microsystems and Solid State Technologies EMFTL. Frank University of RegensburgC. Danner University of RegensburgL. Pütz University of RegensburgK. Krieg Fraunhofer Institute for Translational Medicine and Pharmacology ITMPO. Pless Fraunhofer Institute for Translational Medicine and Pharmacology ITMPJ. Wegener University of Regensburg
|
P64
|
|
P65
|
|
P66
|
|
P67
|
|